Aisling Barrett (@abarretthaem) 's Twitter Profile
Aisling Barrett

@abarretthaem

Doctoral candidate @UniOfOxford
UK Hodgkin Lymphoma subgroup ECR @UKECRC
@EHA_Hematology CRTH scholar
@ECMC_UK JING Steering Group Member
@tcddublin alumnus

ID: 1392210444614569985

calendar_today11-05-2021 20:10:23

96 Tweet

235 Followers

109 Following

Graham Collins (@graham74gc) 's Twitter Profile Photo

Great news - NICE have approved AVD-BV for 1L treatment of advanced stage Hodgkin Lymphoma. Great to have an additional option for these patients. #lymsm nice.org.uk/news/articles/…

Aisling Barrett (@abarretthaem) 's Twitter Profile Photo

Very nice to explore Olomouc this morning and looking forward to speaking later at the Olomoucké Hematologické Dny. Kudos to Vít Procházka 🇨🇿🇪🇺🇺🇦 for his excellent hosting of this wonderful meeting!

Very nice to explore Olomouc this morning and looking forward to speaking later at the Olomoucké Hematologické Dny. Kudos to <a href="/vit_prochazka/">Vít Procházka 🇨🇿🇪🇺🇺🇦</a> for his excellent hosting of this wonderful meeting!
Aisling Barrett (@abarretthaem) 's Twitter Profile Photo

Great to see UK pivotal MCL data (ENRICH) being presented at Olomoucké Hematologické Dny by Dr Klener. A practice changing study 👏

Great to see UK pivotal MCL data (ENRICH) being presented at Olomoucké Hematologické Dny by Dr Klener. A practice changing study 👏
Raul Cordoba, MD, PhD (@drraulcordoba) 's Twitter Profile Photo

Aisling Barrett, European Hematology Association #CRTH 2025 scholar, to present the ASSOCIATION BETWEEN ANTHRACYCLINE USE AND CLINICAL OUTCOMES IN NEARLY 2,000 ENGLISH PATIENTS AGED 60-79 👵👨‍🦳 WITH CLASSICAL HODGKIN LYMPHOMA at XXXVII Olomoucké Hematologické Dny 2025 🇨🇿 #lymsm #geriheme #CardioOnc

<a href="/ABarrettHaem/">Aisling Barrett</a>, <a href="/EHA_Hematology/">European Hematology Association</a> #CRTH 2025 scholar, to present the ASSOCIATION BETWEEN ANTHRACYCLINE USE AND CLINICAL OUTCOMES IN NEARLY 2,000 ENGLISH PATIENTS AGED 60-79 👵👨‍🦳 WITH CLASSICAL HODGKIN LYMPHOMA at XXXVII Olomoucké Hematologické Dny 2025 🇨🇿 #lymsm #geriheme #CardioOnc
Aisling Barrett (@abarretthaem) 's Twitter Profile Photo

Thank you so much for the invitation to speak on our NHS registry analysis David Cutter and looking forward to further collaboration with the Czech Hodgkin Study Group on the HoOP study Graham Collins exciting things to come!

Raul Cordoba, MD, PhD (@drraulcordoba) 's Twitter Profile Photo

#Hematology Clonal relatedness as a prognostic marker in #Richter transformation of chronic lymphocytic leukemia #CLL: a systematic review | ⁦Blood Advances⁩ #CLLsm #lymsm #leusm ashpublications.org/bloodadvances/…

Vít Procházka 🇨🇿🇪🇺🇺🇦 (@vit_prochazka) 's Twitter Profile Photo

Heading to #icml25 by the train called A Einstein. There’s no way this is just a coincidence! Looking forward to meeting all the geniuses in the 🆎💉field. 🫡

Heading to #icml25 by the train called A Einstein. There’s no way this is just a coincidence! Looking forward to meeting all the geniuses in the 🆎💉field. 🫡
European Hematology Association (@eha_hematology) 's Twitter Profile Photo

Applications are ongoing for our 2026 Clinical Research Training in Hematology (#CRTH) program. This unique, nine-month-long training and mentoring experience is designed to help early-career researchers build a successful career in clinical hematology research.  Successful

Applications are ongoing for our 2026 Clinical Research Training in Hematology (#CRTH) program. This unique, nine-month-long training and mentoring experience is designed to help early-career researchers build a successful career in clinical hematology research. 

Successful
Aisling Barrett (@abarretthaem) 's Twitter Profile Photo

If you’re at #ICML2025 come by my poster 1230-1300. We examine survival by anthracycline use in older cHL patients. TLDR: use anthracycline if at all possible! David Cutter Graham Collins

If you’re at #ICML2025 come by my poster 1230-1300. We examine survival by anthracycline use in older cHL patients. TLDR: use anthracycline if at all possible! <a href="/DavidJCutter/">David Cutter</a> <a href="/graham74GC/">Graham Collins</a>
Raul Cordoba, MD, PhD (@drraulcordoba) 's Twitter Profile Photo

Huge interest in older patients 👵👴 with #Hodgkin #Lymphoma at #18ICML #icml2025. Don’t miss posters P365 by Aisling Barrett, P366 by Peiqi Zhao, and P367 by Eva Domingo-Domenech. There is so much room for improvement in this area. Let’s work together in collaborative projects 🇪🇸🇬🇧🇨🇳 #lymsm

Huge interest in older patients 👵👴 with #Hodgkin #Lymphoma at #18ICML #icml2025. Don’t miss posters P365 by <a href="/ABarrettHaem/">Aisling Barrett</a>, P366 by Peiqi Zhao, and P367 by <a href="/Evadodo23/">Eva Domingo-Domenech</a>. There is so much room for improvement in this area. Let’s work together in collaborative projects 🇪🇸🇬🇧🇨🇳 #lymsm
Graham Collins (@graham74gc) 's Twitter Profile Photo

Great work by Aisling Barrett. NHSE data, older #Hodgkin pts. Outcomes ⬆️ with dox. Clearly may reflect selection, but interesting assocn seen between regional difference in dox use and outcome. Take home message: if safe to use dox then do use it! #18ICML #ICML25 #lymsm

Great work by <a href="/ABarrettHaem/">Aisling Barrett</a>. NHSE data, older #Hodgkin pts. Outcomes ⬆️ with dox. Clearly may reflect selection, but interesting assocn seen between regional difference in dox use and outcome. 

Take home message: if safe to use dox then do use it! 

#18ICML #ICML25 #lymsm
Graham Collins (@graham74gc) 's Twitter Profile Photo

It’s back and it’s online. The fantastic #lymphomaManagement course. With much thanks to LymphomaAction for their support as always. Do sign up to learn about state of the art management of this fascinating disease from international experts. #lymsm

Toby Eyre (@tobyeyre82) 's Twitter Profile Photo

- Delighted to present new state of art ESMO - Eur. Oncology Lymphoma living guideline - Covering 7 major lymphoma subtypes - Mx algorithms & recommendations - Detailed supplementary with key up-to-date evidence - In press now Annals of Oncology - open access #lymsm annalsofoncology.org/article/S0923-…

- Delighted to present new state of art <a href="/myESMO/">ESMO - Eur. Oncology</a> Lymphoma living guideline
- Covering 7 major lymphoma subtypes
- Mx algorithms &amp; recommendations 
- Detailed supplementary with key up-to-date evidence
- In press now <a href="/Annals_Oncology/">Annals of Oncology</a>
- open access #lymsm 

annalsofoncology.org/article/S0923-…